Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Accenture
US Department of Justice
Boehringer Ingelheim
Colorcon
Deloitte
Merck
Healthtrust
Federal Trade Commission
Cerilliant

Generated: February 21, 2018

DrugPatentWatch Database Preview

Bayer Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?

BAYER PHARMS has thirty-one approved drugs.



Summary for Bayer Pharms
US Patents:0
Tradenames:24
Ingredients:23
NDAs:31

Drugs and US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms LITHANE lithium carbonate TABLET;ORAL 018833-001 Jul 18, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms STILPHOSTROL diethylstilbestrol diphosphate INJECTABLE;INJECTION 010010-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms CORT-DOME hydrocortisone LOTION;TOPICAL 009895-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms MIXTARD HUMAN 70/30 insulin recombinant purified human; insulin susp isophane semisynthetic purified human INJECTABLE;INJECTION 019585-001 Mar 11, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms AZLIN azlocillin sodium INJECTABLE;INJECTION 050562-002 Sep 3, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062333-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062372-001 May 13, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms RADIO-IODINATED (I 125) SERUM ALBUMIN (HUMAN) albumin iodinated i-125 serum INJECTABLE;INJECTION 017846-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 062372-004 Mar 2, 1988 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 3,839,573 ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-002 Jun 26, 1997 5,006,530 ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 5,006,530 ➤ Sign Up
Bayer Pharms ADALAT nifedipine CAPSULE;ORAL 019478-001 Nov 27, 1985 3,644,627 ➤ Sign Up
Bayer Pharms ADALAT nifedipine CAPSULE;ORAL 019478-002 Sep 17, 1986 3,784,684 ➤ Sign Up
Bayer Pharms CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ciprofloxacin INJECTABLE;INJECTION 019858-001 Dec 26, 1990 4,705,789*PED ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-006 Jul 24, 2000 5,006,530 ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-004 Jun 26, 1997 5,177,080 ➤ Sign Up
Bayer Pharms BAYCOL cerivastatin sodium TABLET;ORAL 020740-001 Jun 26, 1997 5,177,080 ➤ Sign Up
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 3,799,934 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
US Department of Justice
Argus Health
UBS
US Army
McKinsey
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot